Viatin 50 mg (Sitagliptin Hydrochloride Hydrate)

Adult dosage

This medication is administered once daily at a dose of 100 mg for monotherapy or combination therapy, with a maximum daily dose of 100 mg. Dose adjustments are required for patients with renal impairment. No dose adjustment is needed for mild and moderate renal impairment (eGFR 45 to less than 90). For moderate renal impairment (eGFR 30 to less than 45), a dose of 50 mg once daily is recommended. For severe renal impairment or patients requiring hemodialysis or peritoneal dialysis:

This medication can cause serious allergic reactions in some individuals. Such reactions may include anaphylaxis, angioedema, and severe skin conditions. Symptoms may appear within three months after taking the drug, so if these symptoms are suspected, discontinue the medication immediately and consult a physician. This medication may also cause a serious side effect known as acute pancreatitis, so it is important to carefully monitor for symptoms of pancreatitis. If pancreatitis is suspected, discontinue the drug immediately and seek medical attention. This medication should not be used in patients with type 1 diabetes or in those with diabetic ketoacidosis. Patients with a known severe allergy to this medication or its components should not use it. Patients with impaired kidney function may require a dose adjustment, and it is important to regularly monitor kidney function. Caution is especially needed when using this medication in conjunction with insulin or sulfonylureas, as there is a risk of hypoglycemia. Immediate action should be taken if symptoms of hypoglycemia occur, and adjusting the dose of other medications may be necessary. This medication may cause rare side effects, such as severe arthralgia or blistering disorders like pemphigoid, so if these symptoms occur, it is important to inform a physician immediately. Use of this medication is not recommended during pregnancy or lactation, and safety and efficacy have not been established in children and adolescents under 18 years of age. Elderly patients may have decreased kidney function, so dose adjustment and kidney function testing are necessary. In case of overdose, general treatment may be accompanied by consideration of hemodialysis if necessary. It is important to consult healthcare professionals if abnormal symptoms occur while taking this medication.

Serious side effects

Urticaria, severe swelling (angioedema), anaphylaxis, skin rash, Stevens-Johnson syndrome, pancreatitis, acute pancreatitis, acute kidney failure, severe arthralgia, bullous pemphigoid, elevated liver enzymes, liver abnormalities (symptoms indicating jaundice not specified), severe hypoglycemia, pneumonia, diabetic complications, metabolic acidosis, cardiac arrest

Mild side effects

• Headache
• upper respiratory tract infection
• nasopharyngitis
• constipation
• vomiting
• myalgia
• limb pain
• back pain
• pruritus
• diarrhea

This medication should be stored in a sealed container to prevent air exposure, ideally at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's efficacy for a longer period.

Appearance

Orange, biconvex, round film-coated tablet

Package unit

30 tablets (10 tablets/PTP X 3)